Human Platelet Lysate (HPL) as an Alternative Media Propagation of T47D Cells Line

Diani Mentari, Relita Pebrina, Diah Nurpratami

Abstract


Fetal bovine serum (FBS) is a gold standard as a supplement to cell and tissue culture media. This is due to a large number of Growth Factor (GF) contained in FBS. However, the use of FBS is at risk of transferring endotoxins, prions, bacteria and viruses from animals to humans, so it is risky to be used on cell therapy. Human Platelet Lysate (HPL) is a medium that can be developed as an alternative cell growth medium. The advantage of HPL is that it does not contain aggregate platelets so it does not cause the cells to clot. This condition causes HPL to be used as a substitute medium replacing FBS for cell propagation. The use of HPL for cell propagation has been widely reported. However, the use of HPL in cancer cells has not been found. Thus, this study aims to see the effectiveness of HPL as a T47D cell culture medium. The study began with donor selection with criteria for the male sex, the blood type O, the age ≤35 years. Furthermore, the Platelet Concentrate (PC) was processed into HPL then measured pH, total protein and albumin levels. The cell viability was measured using the MTT assay to determine the ability of cell proliferation when propagation using HPL. The doubling time test was carried out as in the cell proliferation test. However, the incubation was carried out for 24 h, 48 h and 72 h and the HPL concentration used was 5%. The result shows that HPL 10% and 20% ability to increase proliferation better than the FBS 10%. HPL with a 5% concentration ability to shortens the doubling time than FBS 10% (doubling time is less than 19.94 h). It this study, cell proliferation is influenced by the pH of HPL and total protein but not by the amount albumin.


Keywords: Human Platelet Lysate, Proliferation, T47D cell line, total protein, albumin.


Full Text:

PDF

References


AVMA, 2013, FBS and Animal Welfare, American Veterinary Medical Association AVMA Guidelines for the Euthanasia of Animals.

Baik, S.Y., Lim, Y.A., Kang, S.J., Ahn, S.H., Lee, W. G. and Kim, C.H., 2014, Effects of Platelet Lysate Preparations on the Proliferation of HaCaT Cells, Ann Lab Med, 34, 43-50.

Biran, A., Zada, L., Karam, P.A., Vadai, E., Roitman, L., Ovadya, Y., Porat, Z. and Krizhanovsky, V., 2017, Quantitative identification of senescent cells in aging and disease, Aging Cell, 16(4), 661–671.

Brunne, D., Frank, J., Appl, H., Schöffl, H., Pfaller, W. and Gstraunthaler, G., 2010, Serum-free Cell Culture: The Serum-free Media Interactive Online Database, Altex, 27(1), 53-62.

Carlo, L., Balduini and Noris, P., 2014, Platelet Count and Aging, Hematologica, 99 (6), 953-955.

Cheng, X.M., Xu, X., Liu, J., Mei, B., Fu, P. and Zhao, D., 2017, Panax ginseng total protein promotes proliferation and secretion of collagen in NIH/3T3 cells by activating extracellular signal-related kinase pathway, Journal of Ginseng Research, 41(3), 411-418.

Cowper, M., Frazier, T., hy, X., Curley, J.L., Ma, M.H., Mohiuddin, O.A., Dietrich, M., McCarthy, M., Bukowska, J. and Gimble, J.M., 2019, Human Platelet Lysate as a Functional Substitute for Fetal Bovine Serum in the Culture of Human Adipose Derived Stromal/Stem Cells, Cells., 8(7), 724.

Doucet, C., Ernou, I., Zhang, Y., LIense, J-R., Begot, L., Holy, X. and Lataillade, J-J., 2005, Platelet lysates promote mesenchymal stemcell expansion: A safety substitute for animal serum in cell-based therapy applications, Journal of Cellular Physiology, 205(2), 228-236.

Durante, C., Agostini, F., Abbruzzese, L., Toffola, R.T., Zanolin, S., Suine, C. and Mazzucato, M., 2013, Growth factor release from platelet concentrates: analytic quantification and characterization for clinical applications, VoxSanguinis, 105(2), 129-136.

Evanson, R., Guyton, K. and Oliver, D.L., 2014, Gender and Age Differences in Growth Factor Concentrations From Platelet-Rich Plasma in Adults, Military Medicine, 179(7), 799.

Fernandez-Rebollo, E., Mentrup, D., Ebert R., Franzen, J., Abagnale, G., Sieben, T., Ostrowska, A., Hoffmann, P., Roux, P-F., Rath, B., Goodhardt, M., Lemaitre, J-M., Bischof, O., Jakob, F. and Wagner, W., 2017, Human Platelet Lysate versus Fetal Calf Serum: These Supplements Do Not Select for Different Mesenchymal Stromal Cells, Scientific Reports, 7, 5131.

Foulkes, W,D., 2007, Gene p53 Master and Commander, The New England Jurnal of Medecine, 357(25), 2539-2541.

Francis, G.L., 2010, Albumin and mammalian cell culture: implications for biotechnology applications, Cytotechnology, 62(1), 1–16.

Freshney, R,I., 2000, Culture of Animal Cells: A manual of Basic Techniques, 4th Ed Wiley- Lies. Canada.

Goel, R., Ness, P.M., Takemoto, C.M., Krishnamurti, L., King, K.E. and Tobian, A.A., 2015, Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality, Blood, 125(9), 1470–1476.

Hemeda, H., Giebel, B. and Wagner, W., 2014, Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells, Cytotherapy, 16, 170-180.

Kholmukhamedov, A. and Jobe, S., 2019, Platelet respiration, Blood Advances, 3(4), 599-602.

Lohmann, M., Walenda, G, Hemeda, H., Joussen, S., Drescher, W., Jockenhoevel, S., Hutschenreuter, G., Zenke, M. and Wagner, W., 2012, Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells, PLoS One, 7(5), e37839.

Meiyanto, E., Sismindari, Candra, L. and Moordiani, 2003, Efek Antiproliferatif Ekstrak Etanol Daun dan Kulit Batang Tanaman Cangkring (Erythrina fusca Lour.) terhadap Sel HeLa, Majalah Farmasi Indonesia, 14(3), 124-131.

Mentari, D., Pebrina, R. and Nurpratami, D., 2020, Effect Storage of pH, Glucose Level, LDH, Calcium and MPV as a Quality Indicator of Trombocyte Concentrate, Biomedika. Feb.12 (1).

Mohammadi, S., Nikbakht, M., Mohammadi, A,M., Panah, M.Z., Ostadali, M.R., Nasiri, H. and Ghavamzadeh, A., 2016, Human Platelet Lysate as a Xeno Free Alternative of Fetal Bovine Serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells, International Journal of Hematology-Oncology and Stem Cell Reserach, 10(3), 161-172.

Nugraha, Y., Sari, P., Purwoko, R.Y., Luviah, E. and Adiwinata, J., 2014, Effect of lysed platelet count in platelet concentrates on various growth factor levels after freeze thaw cycles, International Journal of PharmTech Research., 6(7), 2036-2042.

Petraszko, T. and Zeller, M., 2016, Canadian Blood Service: Platelet Transfution, Alloimunization and Management of Platelet Refractoriness. https://profedu.blood.ca/en/transfusion/clinical-guide/platelet-transfusion-alloimmunization-and-management-platelet accessed on September 10th 2019.

Permenkes RI, 2015, Peraturan Menteri Kesehatan Republik Indonesia No. 91 tentang Standar Pelayanan Darah, Jakarta, Retrieved from https://www.kemhan.go.id/itjen/wp-content/uploads/2017/03/bn36-2016.pdf

Pierce, 2003, Technical Resource. Protein stability and storage. http://wolfson.huji.ac.il/purification/PDF/StorageProteins/PIERCE_ProteinStorage.pdf, accces on 10th Sep 2019.

Regulation of the Minister of Health of the Republic of Indonesia Number 91 Year 2015 Concerning Blood Transfusion Service Standards.

Schafer, J.M., Lee, E.S., O’Regan, R.M., Yao, K and Jordan, V.C, 2000, Rapid Development of Tamoxifen-Stimulated Mutant p53 Breast Tumors (T47D) in Athymic Mice, Clin Cancer Res., 6, 4373-4380.

Vagenende, V., Yap, M.G and Trout, B,L., 2009, Mechanisms of protein stabilization and prevention of protein aggregation by glycerol, Biochemistry, 48(46), 11084-96.

Varna, M., Bousquet, G, Plassa, L-F., Bertheau, P. and Janin, A., 2011, TP53 Status and Response to Treatment in Breast Cancers, Journal of Biomedicine and Biotechnology, 2011(1), 1-9.

Weibrich, G., Kleis, W.K., Hafner, G, Hitzler, W.E, 2002, Growth factor levels in platelet-rich plasma and correlations with donor age, sex and platelet count, J Craniomaxillofac Surg, 30(2), 97-102.

Wen, Y.H., Lin, W.Y., Lin, C.J. and Sun, Y.C., 2018, Sustained or higher levels of growth factors in platelet-rich plasma during 7-day storage, Clinica Chimica Acta, 483, 89-93.

Witzenedera, K., Lindenmair, A., Gabriela, V. and Höllera, K., 2013, Human-Derived Alternatives to Fetal Bovine Serum in Cell Culture, Transfus Med Hemother, 40, 417–423.




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev11iss1pp36-45

Copyright (c) 2020 Diani Mentari

Indexed by:

               

               

      

 

Indonesian Society for Cancer Chemoprevention